ROCCUZZO, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 324
EU - Europa 175
AS - Asia 18
AF - Africa 12
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 533
Nazione #
US - Stati Uniti d'America 321
IT - Italia 98
IE - Irlanda 35
SE - Svezia 21
NG - Nigeria 12
SG - Singapore 7
IN - India 5
FR - Francia 4
UA - Ucraina 4
CA - Canada 3
CN - Cina 3
CZ - Repubblica Ceca 3
FI - Finlandia 3
BE - Belgio 2
BR - Brasile 2
ES - Italia 2
HK - Hong Kong 2
AU - Australia 1
DE - Germania 1
EU - Europa 1
JP - Giappone 1
MK - Macedonia 1
NL - Olanda 1
Totale 533
Città #
Chandler 94
Dublin 35
Rome 24
Ashburn 22
Nyköping 19
Turin 18
Milan 14
Abuja 12
Medford 11
Princeton 11
Singapore 7
New York 6
Ann Arbor 5
Boston 4
Lappeenranta 3
Prague 3
Pune 3
Seattle 3
Toronto 3
Andover 2
Barcelona 2
Bari 2
Brussels 2
Hebei 2
Novara 2
Paris 2
Washington 2
West Jordan 2
Atlanta 1
Baricella 1
Beijing 1
Boardman 1
Cape Coral 1
Cheyenne 1
Eitensheim 1
Genova 1
Grugliasco 1
Huskvarna 1
Jenera 1
Los Angeles 1
Mountain View 1
Nijmegen 1
Noida 1
Norwalk 1
Osasco 1
Torino 1
Upper Marlboro 1
Woodbridge 1
Totale 335
Nome #
Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials 50
Folliculotropic Mycosis Fungoides: Current Guidance and Experience from Clinical Practice 47
Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome? 42
Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study 41
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives 34
Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult-to-treat population 33
Cutaneous B-cell lymphomas: Update on diagnosis, risk-stratification, and management 30
Guttate psoriasis in a patient with mycosis fungoides in treatment with Brentuximab vedotin: An unreported association 30
Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis 28
Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System 26
Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma 26
SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review 20
Drug survival and efficacy of anti-interleukin 23 biologics in psoriasis: a comparative study on different agents 19
Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study 13
Clinical outcomes and management of JAK inhibitor-associated acne (JAKne) in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study 12
Regression of human papillomavirus-associated high-grade vaginal intraepithelial neoplasia after switching from ustekinumab to risankizumab in a psoriasis patient 11
Obesity and immune-checkpoint inhibitors in advanced melanoma: A meta-analysis of survival outcomes from clinical studies 11
Ocular Surface Disease in Patients With Atopic Dermatitis Treated With Dupilumab: A Prospective Case-Control Study 9
Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC-CLTG/ISCL survey 9
BRCA1-associated protein 1 c.368delG mutation leads to the development of multiple BAPomas and cutaneous melanomas: A novel pathogenic variant in BRCA1-associated protein tumor predisposition syndrome 9
Synchronous occurrence of primary cutaneous B-cell lymphoma and cutaneous Rosai-Dorfman disease in distinct lesions: A unique association 8
Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitals 7
Impact of comorbidities in the response of atopic patients treated with dupilumab: a real-life study up to 36 weeks 7
Visual symptoms in a patient treated with MEK inhibitors 7
Retinoid-associated myopia in dermatologic patients: a systematic review 6
Emerging prognostic biomarkers in advanced cutaneous melanoma: a literature update 6
Predictors of recurrence and progression in poorly differentiated cutaneous squamous cell carcinomas: insights from a real-life experience 5
Time to next treatment and safety assessment in cutaneous-T-cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin 5
Mixed purpuric and maculopapular eruption in a 70-year-old woman 4
Switching from adalimumab originator to biosimilars in hidradenitis suppurativa: What's beyond cost-effectiveness? 4
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate‐to‐severe atopic dermatitis: A nationwide retrospective cohort study 4
Clinical effectiveness of IL-17 and IL-23 inhibitors on difficult-to-treat psoriasis areas (scalp, genital, and palmoplantar sites): a retrospective, observational, single-center, real-life study 4
Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study 4
Cutaneous adverse reactions following SARS‐CoV‐2 vaccine booster dose: a real‐life multicentre experience 3
Maculopapular rash: An overlooked monkeypox diagnostic clue? 3
Phenotypic and Dermoscopic Patterns of Familial Melanocytic Lesions: A Pilot Study in a Third-Level Center 2
Exploring Psoriasis Inflammatory Microenvironment by NanoString Technologies 2
Concomitant cutaneous graft-versus-host disease and solid organ rejection: an unreported presentation 1
Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice? 1
Totale 583
Categoria #
all - tutte 4.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.235


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202273 0 0 0 1 2 0 6 2 1 5 13 43
2022/2023309 20 33 4 20 23 39 14 72 29 5 31 19
2023/2024201 19 42 20 12 9 44 11 12 6 22 4 0
Totale 583